Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy

Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy

Human papillomavirus (HPV)-related, p16-positive oropharyngeal carcinoma is considered to be sensitive to anticancer drugs, and the standard treatment is therefore chemoradiotherapy, rather than surgery, especially for aggressive disease. However, with this higher sensitivity, chemotherapy alone may...

Full description

Bibliographic Details
Main Authors: Daisuke Inukai, Taichi Kan, Shunpei Yamanaka, Hiroki Okamoto, Yasushi Fujimoto, Takanori Ito, Natsuki Taniguchi, Yuuki Yamamoto, Toyonori Tsuzuki, Akiyoshi Takami, Tetsuya Ogawa
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Microorganisms
Subjects:
p16-positive oropharyngeal carcinoma
neoadjuvant chemotherapy
pathological complete remission
Online Access:https://www.mdpi.com/2076-2607/8/10/1497

Similar Items

Similar Items